+ Site Statistics
+ Search Articles
+ PDF Full Text Service
How our service works
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ Translate
+ Recently Requested

Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats



Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats



Pharmacology 62(2): 107-112



Complexation of ursodeoxycholic acid (UDCA) with 2-hydroxypropyl-beta-cyclodextrin (HPbetaCD) improves the water solubility and the dissolution rate of UDCA and may therefore increase its bioavailability. We compared the amount and the rate of biliary excretion of UDCA and biliary lipid secretion after a single oral administration of UDCA in 3 different pharmaceutical formulations (UDCA-HPbetaCD ('urso-beta-cyclodextrin'), UDCA suspension and UDCA capsule) at 3 different dosages each, in 11 groups (2 control groups) of bile fistula rats. UDCA excretion increased with an increase in dose, biliary UDCA recov-ery and peak secretion were significantly higher after administration of UDCA-HPbetaCD than after UDCA in suspension or capsule. This enhancement of biliary excretion may achieve greater UDCA enrichment in the bile acid pool than conventional pharmaceutical UDCA formulations, this giving to UDCA-HPbetaCD a considerable therapeutical potential.

Please choose payment method:






(PDF emailed within 1 workday: $29.90)

Accession: 047890677

Download citation: RISBibTeXText

PMID: 11174081


Related references

Ursodeoxycholic acid complexation with 2-hydroxypropyl-beta-cyclodextrin increases ursodeoxycholic acid biliary excretion after single oral administration in rats. Journal of Hepatology 28(SUPPL 1): 126, 1998

2-Hydroxypropyl-beta-cyclodextrin complexation with ursodeoxycholic acid. International Journal of Pharmaceutics (Amsterdam) 118(1): 77-83, 1995

Improvement of ursodeoxycholic acid bioavailability by 2-hydroxypropyl-beta-cyclodextrin complexation in healthy volunteers. Pharmacological Research 31(3-4): 205-209, 1995

Tauro-ursodeoxycholic acid vs. ursodeoxycholic acid in the dissolution of biliary calculi. Results of a single blind study. La Clinica Terapeutica 143(5): 421-428, 1993

Improved bioavailability of ursodeoxycholic acid by inclusion in 2-hydroxypropyl-beta-cyclodextrin. Journal of Hepatology 18(SUPPL 1): S167, 1993

Evidence that ursodeoxycholic acid increases biliary excretion of cholic acid and chenodeoxycholic acid in man. Gastroenterology 106(4 SUPPL ): A935, 1994

DELTA-22-ursodeoxycholic acid, a unique metabolite of administered ursodeoxycholic acid in rats, indicating partial beta-oxidation as a major pathway for bile acid metabolism. Biochemistry. 34(13): 4169-4178, 1995

Complexation of ursodeoxycholic acid with beta-cyclodextrin-choline dichloride coprecipitate. International Journal of Pharmaceutics 190(2): 139-153, 1999

Unsaturation of ursodeoxycholic acid in chronic ursodeoxycholic administration in rats. Gastroenterology 106(4 SUPPL ): A1018, 1994

Ofloxacin and ursodeoxycholic acid versus ursodeoxycholic acid alone to prevent occlusion of biliary stents: a prospective, randomized trial. Endoscopy 33(6): 491-494, 2001

Ursodeoxycholic acid and prednisolone versus ursodeoxycholic acid and placebo in the treatment of early stages of primary biliary cirrhosis. Journal of Hepatology 25(1): 49-57, 1996

Positive responses to methotrexate and ursodeoxycholic acid in patients with primary biliary cirrhosis responding insufficiently to ursodeoxycholic acid alone. Journal of Hepatology 18(1): 9-14, 1993

The effects of colchicine and methotrexate are additive to ursodeoxycholic acid for patients with primary biliary cirrhosis who respond incompletely to ursodeoxycholic acid. Hepatology 26(4 PART 2): 438A, 1997

A randomized trial comparing colchicine and ursodeoxycholic acid combination to ursodeoxycholic acid in primary biliary cirrhosis. Hepatology. 24(5): 1098-1103, 1996

Therapeutic Equivalence of Ursodeoxycholic Acid Tablets and Ursodeoxycholic Acid Capsules for the Treatment of Primary Biliary Cirrhosis. Clinical Pharmacology in Drug Development 2(3): 231-236, 2013